Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Reply.

Lista G, Lughezzani G, Buffi NM, Lazzeri M, Larcher A, Dell'Oglio P, Porter J, Ficarra V, Mottrie A, Guazzoni G.

Urology. 2015 Mar;85(3):595. doi: 10.1016/j.urology.2014.09.070. No abstract available.

PMID:
25733272
2.

Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project).

Lista G, Buffi NM, Lughezzani G, Lazzeri M, Abrate A, Mistretta A, Larcher A, Dell'Oglio P, Fossati N, Porter J, Ficarra V, Mottrie A, Guazzoni G.

Urology. 2015 Mar;85(3):589-95. doi: 10.1016/j.urology.2014.09.068.

PMID:
25733270
3.

Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses.

Larcher A, Fossati N, Mistretta F, Lughezzani G, Lista G, Dell'Oglio P, Abrate A, Sun M, Karakiewicz P, Suardi N, Lazzeri M, Montorsi F, Guazzoni G, Buffi N.

Urol Oncol. 2015 Jan;33(1):22.e1-9. doi: 10.1016/j.urolonc.2014.09.003. Epub 2014 Oct 7.

PMID:
25301741
4.

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.

Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M.

Eur Urol. 2014 Aug 16. pii: S0302-2838(14)00686-1. doi: 10.1016/j.eururo.2014.07.034. [Epub ahead of print]

PMID:
25139197
5.

Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.

Abrate A, Lazzeri M, Lughezzani G, Buffi N, Bini V, Haese A, de la Taille A, McNicholas T, Redorta JP, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Freschi M, Guazzoni G.

BJU Int. 2015 Apr;115(4):537-45. doi: 10.1111/bju.12907.

PMID:
25130593
6.

Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.

Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Buffi N, Guazzoni G, Lazzeri M.

Korean J Urol. 2014 Jul;55(7):436-45. doi: 10.4111/kju.2014.55.7.436. Epub 2014 Jul 11.

7.

Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.

Mistretta F, Buffi NM, Lughezzani G, Lista G, Larcher A, Fossati N, Abrate A, Dell'Oglio P, Montorsi F, Guazzoni G, Lazzeri M.

Biomed Res Int. 2014;2014:987149. doi: 10.1155/2014/987149. Epub 2014 May 8. Review.

8.

Robot-assisted, single-site, dismembered pyeloplasty for ureteropelvic junction obstruction with the new da Vinci platform: a stage 2a study.

Buffi NM, Lughezzani G, Fossati N, Lazzeri M, Guazzoni G, Lista G, Larcher A, Abrate A, Fiori C, Cestari A, Porpiglia F.

Eur Urol. 2015 Jan;67(1):151-6. doi: 10.1016/j.eururo.2014.03.001. Epub 2014 Mar 13.

PMID:
24656756
9.

Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.

Fossati N, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Lughezzani G, Gadda GM, Lista G, Larcher A, Abrate A, Mistretta F, Bini V, Redorta JP, Graefen M, Guazzoni G.

BJU Int. 2014 Mar 3. doi: 10.1111/bju.12718. [Epub ahead of print]

PMID:
24589357
10.

[Focal therapy and prostate cancer].

Lazzeri M, Losa A, Buffi N, Lughezzani G, Fossati N, Abrate A, Larcher A, Lista G, Mistretta A, Guazzoni G.

Urologia. 2013 Sep-Dec;80(4):283-9. doi: 10.5301/RU.2013.11667. Epub 2013 Dec 9. Review. Italian.

PMID:
24419922
11.

Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature.

Torelli T, Lughezzani G, Catanzaro M, Nicolai N, Colecchia M, Biasoni D, Piva L, Maffezzini M, Stagni S, Necchi A, Giannatempo P, Farè E, Salvioni R.

Tumori. 2013 Sep-Oct;99(5):e203-7. doi: 10.1700/1377.15315. Review.

PMID:
24362870
12.

Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.

Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Palou Redorta J, Graefen M, Guazzoni G.

Eur Urol. 2014 Nov;66(5):906-12. doi: 10.1016/j.eururo.2013.12.005. Epub 2013 Dec 16.

PMID:
24361258
13.

Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.

Lazzeri M, Abrate A, Lughezzani G, Gadda GM, Freschi M, Mistretta F, Lista G, Fossati N, Larcher A, Kinzikeeva E, Buffi N, Dell'Acqua V, Bini V, Montorsi F, Guazzoni G.

Urology. 2014 Mar;83(3):606-12. doi: 10.1016/j.urology.2013.10.016. Epub 2013 Dec 6.

PMID:
24315305
14.

The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience.

Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Crestani A, Guttilla A, Raggi D, Giannatempo P, Necchi A, Pizzocaro G, Colecchia M, Salvioni R, Nicolai N.

J Urol. 2014 Apr;191(4):977-82. doi: 10.1016/j.juro.2013.10.140. Epub 2013 Nov 18.

PMID:
24262497
15.

The Relationship Between Lymph Node Ratio and Cancer-Specific Survival in a Contemporary Series of Patients with Penile Cancer and Lymph Node Metastases.

Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Necchi A, Giannatempo P, Raggi D, Fare E, Colecchia M, Pizzocaro G, Salvioni R, Nicolai N.

BJU Int. 2013 Oct 15. doi: 10.1111/bju.12510. [Epub ahead of print]

PMID:
24128128
16.

A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.

Bianchi M, Gandaglia G, Trinh QD, Hansen J, Becker A, Abdollah F, Tian Z, Lughezzani G, Roghmann F, Briganti A, Montorsi F, Karakiewicz PI, Sun M.

Urol Oncol. 2014 Jan;32(1):46.e1-7. doi: 10.1016/j.urolonc.2013.06.010. Epub 2013 Sep 17.

PMID:
24054864
17.

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.

Lazzeri M, Haese A, Abrate A, de la Taille A, Redorta JP, McNicholas T, Lughezzani G, Lista G, Larcher A, Bini V, Cestari A, Buffi N, Graefen M, Bosset O, Le Corvoisier P, Breda A, de la Torre P, Fowler L, Roux J, Guazzoni G.

BJU Int. 2013 Aug;112(3):313-21. doi: 10.1111/bju.12217.

PMID:
23826841
18.

Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature.

Larcher A, Broglia L, Lughezzani G, Mistretta F, Abrate A, Lista G, Fossati N, Sangalli M, Kuefner D, Cestari A, Buffi N, Lazzeri M, Guazzoni G, Montorsi F.

Curr Urol Rep. 2013 Dec;14(6):620-7. doi: 10.1007/s11934-013-0348-3. Review.

PMID:
23794125
19.

Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy.

Losa A, Gadda GM, Lazzeri M, Lughezzani G, Cardone G, Freschi M, Lista G, Larcher A, Nava LD, Guazzoni G.

Urology. 2013 Jun;81(6):1291-6. doi: 10.1016/j.urology.2012.11.078. Epub 2013 Mar 19.

PMID:
23522299
20.

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.

Scattoni V, Lazzeri M, Lughezzani G, De Luca S, Passera R, Bollito E, Randone D, Abdollah F, Capitanio U, Larcher A, Lista G, Gadda GM, Bini V, Montorsi F, Guazzoni G.

J Urol. 2013 Aug;190(2):496-501. doi: 10.1016/j.juro.2013.02.3184. Epub 2013 Mar 1.

PMID:
23466239
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk